Relistor
1 known investors
RELISTOR is an FDA-approved prescription medication specifically designed to treat opioid-induced constipation (OIC) by targeting the constipating effect of opioids in the gut without affecting central pain relief. It is marketed to patients taking opioid pain medication who experience chronic constipation, and is available in tablet and injection forms.
BiotechDigital Health
Investors · 1
Frequently asked questions
- What does Relistor do?
- RELISTOR is an FDA-approved prescription medication specifically designed to treat opioid-induced constipation (OIC) by targeting the constipating effect of opioids in the gut without affecting central pain relief. It is marketed to patients taking opioid pain medication who experience chronic constipation, and is available in tablet and injection forms.
- Who are Relistor's investors?
- Relistor's investors include HEALTHCARE ROYALTY PARTNERS.